You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 11,446,380


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,446,380 protect, and when does it expire?

Patent 11,446,380 protects OXLUMO and is included in one NDA.

This patent has sixty-one patent family members in forty countries.

Summary for Patent: 11,446,380
Title:Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
Abstract: The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the HAO1 gene, and methods of using such RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1.
Inventor(s): Querbes; William (Boston, MA), Fitzgerald; Kevin (Brookline, MA), Bettencourt; Brian (Groton, MA), Liebow; Abigail (Somerville, MA), Erbe; David V. (Arlington, MA)
Assignee: Alnylam Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:16/673,863
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using USPTO Resources

Introduction

When analyzing the scope and claims of a U.S. patent, such as United States Patent 11,446,380, it is crucial to utilize the various resources and tools provided by the United States Patent and Trademark Office (USPTO) and other international intellectual property offices. This article will guide you through the process, highlighting key steps, tools, and databases necessary for a comprehensive analysis.

Understanding Patent Search Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and patent documents. This tool replaced legacy search tools like PubEast, PubWest, PatFT, and AppFT, offering enhanced and flexible search capabilities[1].

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP offices, including the IP5 Offices. This service is invaluable for seeing the patent family of a specific application, along with classification, citation data, and office actions[1].

Public Search Facility and PTRCs

The USPTO Public Search Facility in Alexandria, VA, and the Patent and Trademark Resource Centers (PTRCs) across the country provide access to patent and trademark information. Trained staff are available to assist with search techniques[1].

Identifying the Patent

To analyze the scope and claims of a specific patent like US 11,446,380, start by locating the patent document.

Accessing the Patent Document

Use the Patent Public Search tool or other databases like PatFT or AppFT to find the full-text document of the patent. These databases provide detailed information on granted patents and published patent applications[1][4].

Analyzing Patent Claims

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset is a valuable resource for detailed analysis of patent claims. This dataset includes claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. It provides individually-parsed claims, claim-level statistics, and document-level statistics, which can help in understanding the scope and dependency of claims[3].

Claim-Level Analysis

  • Claim Dependency: Analyze the dependency relationship between claims to understand how each claim builds upon others.
  • Claim Scope: Use the dataset to evaluate the scope of the patent, including newly-developed measures of patent scope as described in the USPTO Economic Working Paper 2016-04[3].

Evaluating Patent Scope

Subject Matter Eligibility

Ensure that the claims of the patent fall within the subject matter eligibility criteria as outlined by the USPTO. The 2024 Guidance Update on Patent Subject Matter Eligibility provides detailed criteria for evaluating claims[5].

Prior Art and Citation Data

Use tools like the Common Citation Document (CCD) to consolidate prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

International Patent Landscape

Searching International Patent Offices

To understand the global patent landscape, search databases from other international intellectual property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), World Intellectual Property Organization (WIPO), and others. These databases often provide machine translations and full-text searches of international patent applications[1].

Example: Espacenet and PATENTSCOPE

  • Espacenet: This database covers European and international patents, including those from the US, and provides access to machine translations for some languages[4].
  • PATENTSCOPE: This service by WIPO features a full-text search of published international patent applications and includes machine translations for some documents[1].

Additional Resources

Patent Official Gazette

The Electronic Official Gazette allows users to browse issued patents for the current week, classified by type of patent (utility, design, plant). This can help in identifying recent patents in the same field[1].

Patent Assignment Search

If the ownership of the patent has changed, use the Patent Assignment Search website to track these changes. This is crucial for understanding the current legal status and ownership of the patent[1].

Practical Steps for Analysis

Step 1: Locate the Patent Document

Use the Patent Public Search tool or other databases to find the full-text document of US 11,446,380.

Step 2: Analyze Claims

Utilize the Patent Claims Research Dataset to parse and analyze the claims, focusing on claim dependency and scope.

Step 3: Evaluate Prior Art

Use the CCD and other tools to consolidate and analyze prior art citations.

Step 4: Assess International Landscape

Search international patent databases to understand the global patent landscape related to the invention.

Step 5: Check Subject Matter Eligibility

Ensure the claims comply with the subject matter eligibility criteria as per the latest USPTO guidance.

Key Takeaways

  • Use Advanced Search Tools: Leverage the USPTO's Patent Public Search and Global Dossier for comprehensive patent searches.
  • Analyze Claims: Utilize the Patent Claims Research Dataset for detailed claim analysis.
  • Evaluate Prior Art: Consolidate prior art using the CCD and other tools.
  • Assess International Landscape: Search international patent databases to understand the global context.
  • Check Subject Matter Eligibility: Ensure compliance with the latest USPTO guidance on subject matter eligibility.

FAQs

Q: What is the best tool for searching U.S. patents?

A: The USPTO's Patent Public Search tool is highly recommended for its enhanced and flexible search capabilities.

Q: How can I analyze the claims of a U.S. patent?

A: Use the USPTO's Patent Claims Research Dataset to parse and analyze claims, focusing on claim dependency and scope.

Q: Where can I find information on international patent applications?

A: Databases like Espacenet, PATENTSCOPE, and those from other international intellectual property offices provide access to international patent applications.

Q: How do I check if a patent's claims are eligible under U.S. law?

A: Refer to the USPTO's guidance on subject matter eligibility to ensure the claims comply with the latest criteria.

Q: What resources are available for tracking changes in patent ownership?

A: The Patent Assignment Search website allows you to track changes in patent ownership and other related information.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Harvard Business School Library - Patent search: A comparative table of databases. Retrieved from https://asklib.library.hbs.edu/faq/266950
  5. Federal Register - 2024 Guidance Update on Patent Subject Matter Eligibility. Retrieved from https://unblock.federalregister.gov

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,446,380

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alnylam Pharms Inc OXLUMO lumasiran sodium SOLUTION;SUBCUTANEOUS 214103-001 Nov 23, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,446,380

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3204015 ⤷  Subscribe 301167 Netherlands ⤷  Subscribe
European Patent Office 3204015 ⤷  Subscribe PA2022004 Lithuania ⤷  Subscribe
European Patent Office 3204015 ⤷  Subscribe CA 2022 00011 Denmark ⤷  Subscribe
European Patent Office 3204015 ⤷  Subscribe 2022C/509 Belgium ⤷  Subscribe
European Patent Office 3204015 ⤷  Subscribe LUC00252 Luxembourg ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.